Prognostic Value of Baseline and Change of Soluble Suppression of Tumorigenicity-2 in Light Chain Cardiac Amyloidosis

被引：0
|
作者：
Xin, Anran
Li, Xinqing
Huang, Yan
Zhuang, Xiaofeng
Zhao, Xuemei
Wang, Jinxi
Zhou, Ping
Zhang, Jian
Zhang, Yuhui
机构：
来源：
CIRCULATION | 2024年 / 150卷
关键词：
D O I：
10.1161/circ.150.suppl_1.4142598
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4142598
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Soluble form of suppression of tumorigenicity-2 predicts clinical stability of inpatients with community-acquired pneumonia
    Zeng, Yifeng
    Xue, Mingshan
    Zhang, Teng
    Sun, Shixue
    Lin, Runpei
    Li, Ning
    Zheng, Peiyan
    Zhen, Yingjie
    Hu, Haisheng
    Zhang, Xiaohua Douglas
    Sun, Baoqing
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2021, 246 (21) : 2297 - 2306
  • [32] Prognostic value of plasma big endothelin-1 in patients with light chain cardiac amyloidosis
    Chen, Zhongli
    Shi, Anteng
    Wang, Zhiyan
    Chen, Yanjia
    Lin, Yahui
    Su, Mingming
    Dong, Hongbin
    Laptseva, Natallia
    Hu, Yuxiao
    Flammer, Andreas J.
    Duru, Firat
    Jin, Wei
    Chen, Liang
    HEART, 2024, 110 (18) : 1124 - 1132
  • [33] Prognostic value of right ventricular function in light-chain cardiac amyloidosis treated with bortezomib
    Durante-Lopez, Alejandro
    Monivas Palomero, Vanessa
    Torres Sanabria, Mario
    Vazquez Lopez-Ibor, Jorge
    Segovia Cubero, Javier
    Mingo Santos, Susana
    REVISTA ESPANOLA DE CARDIOLOGIA, 2021, 74 (05): : 464 - 466
  • [34] Prevalence and prognostic value of different iron deficiency definitions in light chain cardiac amyloidosis patients
    Li, Xinqing
    Xin, Anran
    Huang, Yan
    Zhou, Qiong
    Wang, Jinxi
    Zhou, Ping
    Anker, Stefan D.
    Zhang, Yuhui
    ESC HEART FAILURE, 2025,
  • [35] Prognostic Value of Soluble Suppression of Tumorigenicity 2 in Chronic Kidney Disease Patients: A Meta-Analysis
    Guo, Guangying
    Huang, Aoran
    Huang, Xin
    Xu, Tianhua
    Yao, Li
    DISEASE MARKERS, 2021, 2021
  • [36] Prognostic Value of the Index of Microcirculatory Resistance Over Serum Biomarkers in Light Chain Cardiac Amyloidosis
    Lee, Joo Myung
    Choi, Ki Hong
    Lee, Seung Hun
    Kim, Soree
    Bak, Minjung
    Park, Kyu Tae
    Choi, Jin-Oh
    Jeon, Eun-Seok
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 74 (13) : B572 - B572
  • [37] The Continuation of Trickle-Down Medicine: Soluble Suppression of Tumorigenicity-2 (sST2) in Pediatric Heart Failure
    Greenway, Steven C.
    CANADIAN JOURNAL OF CARDIOLOGY, 2019, 35 (06) : 692 - 693
  • [38] Soluble Suppression of Tumorigenicity-2 Predicts Mortality and Right Heart Failure in Patients With a Left Ventricular Assist Device
    Numan, Lieke
    Aarts, Emmeke
    Ramjankhan, Faiz
    Oerlemans, Marish I. F.
    van der Meer, Manon G.
    de Jonge, Nicolaas
    Oppelaar, Anne-Marie
    Kemperman, Hans
    Asselbergs, Folkert W.
    Van Laake, Linda W.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2024, 13 (02):
  • [39] SOLUBLE SUPPRESSION OF TUMORIGENICITY-2 PREDICTS HOSPITAL MORTALITY IN BURN PATIENTS: AN OBSERVATIONAL PROSPECTIVE COHORT PILOT STUDY
    Ruiz-Castilla, Mireia
    Bosacoma, Pau
    Dos Santos, Bruce
    Baena, Jacinto
    Guilabert, Patricia
    Marin-Corral, Judith
    Masclans, Joan R.
    Roca, Oriol
    Barret, Juan P.
    SHOCK, 2019, 51 (02): : 194 - 199
  • [40] Circulating soluble suppression of tumorigenicity-2 and the recurrence of atrial fibrillation after catheter ablation: A meta-analysis
    Shi, Yanyu
    Zhang, Zepeng
    Zhang, Tianyang
    Zhang, Linlin
    An, Shan
    Chen, Ying
    BIOMOLECULES AND BIOMEDICINE, 2024, 24 (06): : 1470 - 1481
12345